Skip to main content
Device Global Header

Subscribe
or Renew

Advanced Search

This article is available to subscribers. Subscribe now. Already have an account? Sign in

PerspectiveFree Preview

Risk, Consent, and SUPPORT

List of authors.
  • David Magnus, Ph.D.,
  • and Arthur L. Caplan, Ph.D.

Arguing against a recent OHRP finding, this article emphasizes the difference in research studies between risk associated with standard-of-care treatment and risk associated with assignment to a novel intervention.

Continue reading this article

Select an option below:

Create your account to get 2 free subscriber-only articles each month.

Get Free Access Now Subscribe For Full Access

Already have an account?

Sign In

Print subscriber?

Activate your online access.

Funding and Disclosures

Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.

This article was published on April 18, 2013, at NEJM.org.

Author Affiliations

From the Center for Biomedical Ethics, Stanford University, Stanford, CA (D.M.); and the Division of Medical Ethics, New York University Langone Medical Center, New York (A.L.C.).

Print Subscriber? Activate your online access.